American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 1(65), 2020
DOI: 10.1128/aac.01401-20
Full text: Download
A healthy, intact gut microbiota is often resistant to colonization by gastrointestinal pathogens. During periods of dysbiosis, however, organisms such as Clostridioides difficile can thrive. We describe an optimized in vitro colonization resistance assay for C. difficile in stool (CRACS) and demonstrate the utility of this assay by assessing changes in colonization resistance following antibiotic exposure. Fecal samples were obtained from healthy volunteers ( n = 6) and from healthy subjects receiving 5 days of moxifloxacin ( n = 11) or no antibiotics ( n = 10).